Catalyst Wire Dossier Catalyst Wire Dossier

Tenofovir disoproxil switch

tenofovir disoproxil · Samjin Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tenofovir disoproxil switch, covering 2022-04-01 to 2022-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A phase4 Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B [Phase 4]

See pricing